Studies have pointed that CD4+ CD25+ Foxp3+ regulatory T cells play an immunosuppressive role in antitumor immunity of HCC and significantly affect the prognosis of HCC patients (37, 38). This evidence concerns the gene CD4 and hepatocellular carcinoma.